This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cardosa, M J Articles by Porterfield, J S Search for Related Content PubMed PubMed Citation Articles by Cardosa, M J Articles by Porterfield, J S

 Previous Article  |  Next Article 

J Virol. 1986 March; 57(3): 952-959

Interaction of West Nile virus with primary murine macrophages: role of cell activation and receptors for antibody and complement.

ABSTRACT

We have measured growth of West Nile virus in mouse primary peritoneal macrophages (resident, thioglycolate elicited, and Mycobacterium bovis BCG activated) and in macrophagelike (P338D1) and nonmacrophage (L929, PS clone D) cell lines infected in the absence or presence of specific antibodies (immunoglobulin G ([IgG], IgM), and complement. Monoclonal antibodies directed against Fc receptors (IgG1/2b, 2.4G2) and type 3 complement receptors (Mac-1) were used to define the role of each receptor. Virus yield depended on a balance between enhancement and neutralization and was influenced by the physiologic state of the macrophage, the receptor pathway of viral entry, the mouse strain and age of donor. BCG-activated macrophages displayed a greater ability to restrict West Nile virus than nonactivated cells only in the presence of antiviral IgM, with or without complement; the Fc receptors for various classes of IgG mediated striking enhancement. These studies identify some of the complex innate and acquired factors that determine the interaction between West Nile virus and primary macrophages in vitro.

This article has been cited by other articles:

• Throsby, M., Geuijen, C., Goudsmit, J., Bakker, A. Q., Korimbocus, J., Kramer, R. A., Clijsters-van der Horst, M., de Jong, M., Jongeneelen, M., Thijsse, S., Smit, R., Visser, T. J., Bijl, N., Marissen, W. E., Loeb, M., Kelvin, D. J., Preiser, W., ter Meulen, J., de Kruif, J. (2006). Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus. J. Virol. 80: 6982-6992 [Abstract] [Full Text]  
• Mehlhop, E., Diamond, M. S. (2006). Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203: 1371-1381 [Abstract] [Full Text]  
• Mehlhop, E., Whitby, K., Oliphant, T., Marri, A., Engle, M., Diamond, M. S. (2005). Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection. J. Virol. 79: 7466-7477 [Abstract] [Full Text]  
• Engle, M. J., Diamond, M. S. (2003). Antibody Prophylaxis and Therapy against West Nile Virus Infection in Wild-Type and Immunodeficient Mice. J. Virol. 77: 12941-12949 [Abstract] [Full Text]  
• Shrestha, B., Gottlieb, D., Diamond, M. S. (2003). Infection and Injury of Neurons by West Nile Encephalitis Virus. J. Virol. 77: 13203-13213 [Abstract] [Full Text]  
• Diamond, M. S., Sitati, E. M., Friend, L. D., Higgs, S., Shrestha, B., Engle, M. (2003). A Critical Role for Induced IgM in the Protection against West Nile Virus Infection. J. Exp. Med. 198: 1853-1862 [Abstract] [Full Text]  
• Diamond, M. S., Shrestha, B., Marri, A., Mahan, D., Engle, M. (2003). B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus. J. Virol. 77: 2578-2586 [Abstract] [Full Text]  
• Halstead, S. (1988). Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481 [Abstract]